These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27287013)

  • 1. Prevalence of Vitreoretinal Interface Abnormalities as Detected by Spectral-Domain Optical Coherence Tomography.
    Jacob J; Stalmans P
    Ophthalmologica; 2016; 236(2):81-7. PubMed ID: 27287013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.
    Duker JS; Kaiser PK; Binder S; de Smet MD; Gaudric A; Reichel E; Sadda SR; Sebag J; Spaide RF; Stalmans P
    Ophthalmology; 2013 Dec; 120(12):2611-2619. PubMed ID: 24053995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Concordance, and Heritability of Vitreomacular Interface Abnormalities in a Twin Study.
    Jarrar ZA; Ansari AS; Williams KM; Wong DS; Hysi PG; Mahroo OA; Hammond CJ
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):9. PubMed ID: 37428499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study.
    Meuer SM; Myers CE; Klein BE; Swift MK; Huang Y; Gangaputra S; Pak JW; Danis RP; Klein R
    Ophthalmology; 2015 Apr; 122(4):787-95. PubMed ID: 25556116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Vitreomacular Interface Using High-Resolution OCT in a Population-Based Cohort Study of Older Adults.
    Quinn NB; Steel DH; Chakravarthy U; Peto T; Hamill B; Muldrew A; Graham K; Elliott D; Hennessy R; Cruise S; McGuinness B; Young IS; Kee F; Hogg RE
    Ophthalmol Retina; 2020 Aug; 4(8):801-813. PubMed ID: 32335034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography.
    Koizumi H; Spaide RF; Fisher YL; Freund KB; Klancnik JM; Yannuzzi LA
    Am J Ophthalmol; 2008 Mar; 145(3):509-517. PubMed ID: 18191099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in Presentation of Bilateral Vitreomacular Traction.
    Rodman J; Prete B; Steen J; Shechtman D
    Optom Vis Sci; 2016 Mar; 93(3):310-7. PubMed ID: 26760576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).
    Stalmans P
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Vitreomacular Traction with Foveal Thickness, Subfoveal Choroidal Thickness, and Vitreomacular/Foveal Angle.
    Kozak I; Barteselli G; Sepah YJ; Sadiq MA; High R; Do DV; Nguyen QD
    Curr Eye Res; 2017 Feb; 42(2):297-301. PubMed ID: 27362467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study.
    Cacciamani A; Gattegna R; Pileri M; Di Nicola M; Bardanzellu S; Facciolo G; Cosimi P; Govetto A; Scarinci F
    Int Ophthalmol; 2020 Jan; 40(1):185-193. PubMed ID: 31565760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis.
    Stalmans P; Duker JS; Kaiser PK; Heier JS; Dugel PU; Gandorfer A; Sebag J; Haller JA
    Retina; 2013; 33(10):2003-11. PubMed ID: 23881226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography.
    Zhang Z; Dong F; Zhao C; Dai R; Yu W; Zheng L; He F; Yang Z
    Can J Ophthalmol; 2015 Apr; 50(2):172-9. PubMed ID: 25863860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
    Codenotti M; Iuliano L; Fogliato G; Querques G; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1729-35. PubMed ID: 24764038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin.
    DeCroos FC; Toth CA; Folgar FA; Pakola S; Stinnett SS; Heydary CS; Burns R; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6504-11. PubMed ID: 22879421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical configurations of vitreomacular traction syndrome: influence on clinical course and surgical outcomes.
    Lee EK; Lee SY; Lee JY; Heo JW; Yu HG; Chung H
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1631-1639. PubMed ID: 31104140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal structural changes in a case of spontaneous resolution of vitreomacular traction syndrome: multimodal retinal imaging approach.
    Di Antonio L; Toto L; Aharrh-Gnama A; Ciciarelli V; Mastropasqua A; Carpineto P
    Eur J Ophthalmol; 2015; 25(1):68-72. PubMed ID: 24905253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic full-thickness macular holes and the vitreomacular interface: a high-resolution spectral-domain optical coherence tomography study.
    Takahashi A; Yoshida A; Nagaoka T; Takamiya A; Sato E; Kagokawa H; Kameyama D; Sogawa K; Ishiko S; Hirokawa H
    Am J Ophthalmol; 2012 Nov; 154(5):881-892.e2. PubMed ID: 22958859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Vitreomacular Interface Pathology in a Spanish Tertiary Hospital.
    Flores-Moreno I; Arias-Barquet L; Vidal-Martí M; Muñoz-Blanco A; Rubio-Caso MJ; Ruiz-Moreno JM; Duker JS; Caminal JM
    Ophthalmologica; 2016; 235(3):179-83. PubMed ID: 26886685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
    Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
    Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Preinjection Spectral Domain Optical Coherence Tomography Findings in the Use of Intravitreal Ocriplasmin in a Clinical Setting.
    Wertheimer C; Haritoglou C; Laubichler P; Wolf A; Kaessmann K; Schumann RG; Priglinger S; Mayer WJ
    Ophthalmologica; 2018; 239(1):11-18. PubMed ID: 28954271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.